Dr Reddy's Laboratories reported a 14.5 per cent rise in consolidated Q2 profit to Rs 1,437 crore, driven by strong branded sales. Revenue grew to Rs 8,805 crore, with robust performance in Europe, India, and emerging markets offsetting North America declines

New Delhi: Dr Reddy’s Laboratories on Friday posted a 14.5 per cent increase in its consolidated profit after tax to Rs 1,437 crore for the second quarter ended September 30, aided by robust sales in branded markets.

The Hyderabad-based drug maker reported a profit after tax (PAT) of Rs 1,255 crore in the July-September quarter of the last financial year. Its revenue rose to Rs 8,805 crore in the second quarter against Rs 8,016 crore in the year-ago period, Dr Reddy’s Laboratories said in a regulatory filing.

“Growth in Q2 was dri

See Full Page